| Abstract | Oral Vitamin D(3) is usually administered to children with chronic renal failure in the morning. Is there enough evidence that evening dosing is more beneficial with respect to suppression of parathyroid hormone and reduction of side effects such as hypercalcemia? |
| Authors | Cheryl P Sanchez
(Affiliation: University of Wisconsin Medical School, Madison, WI 53706, USA. cpsanchez at wisc.edu)
|
| Journal | Pediatric nephrology (Berlin, Germany)
(Pediatr Nephrol)
Vol. 19
Issue 7
Pg. 722-3
(Jul 2004)
ISSN: 0931-041X Germany |
| PMID | 15266665
(Publication Type: Journal Article, Review)
|
| Chemical References |
|
| Topics |
- Child
- Cholecalciferol
(administration & dosage)
- Chronotherapy
- Humans
- Hyperparathyroidism, Secondary
(drug therapy)
|
